Literature DB >> 20209390

The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

Volkan Hanci1, Alaeddin Kerimoğlu, Kenan Koca, Aykut Başkesen, Kemal Kiliç, Didem Taştekin.   

Abstract

BACKGROUND: In this study, we investigated the biochemical effectiveness of methylprednisolone, N-acetylcysteine (NAC) and methylprednisolone combined with NAC treatment in experimental spinal cord injury in rats.
METHODS: Thirty-two Sprague-Dawley male rats weighing 250-300 g were divided into four groups. Spinal cord injury was created extradurally with an aneurysm clip at the T4-T5 level. Following the trauma, Group C (Control group, n:8) was not given any treatment. Group M (methylprednisolone group, n:8) was treated with 30 mg x kg(-1) methylprednisolone followed by a maintenance dose of 5.4 mg x kg(-1) per hour. Group N (NAC group, n:8) was given 150 mg x kg(-1) NAC. Group MN (methylprednisolone and NAC group, n:8) was given 30 mg x kg(-1) followed by an hourly maintenance dose of 5.4 mg x kg(-1) methylprednisolone and 150 mg x kg(-1) NAC intraperitoneally. Twenty-four hours after the trauma, the rats were decapitated under anesthesia, and their spinal cord samples were taken for biochemical examination.
RESULTS: Mean malonyldialdehyde (MDA) values in Groups M, N and MN were significantly reduced compared to Group C. Mean superoxide dismutase (SOD) values in Groups M, N and MN were significantly higher than in Group C (p<0.05). No difference existed between Groups M and N with respect to mean MDA and SOD values.
CONCLUSION: Methylprednisolone, NAC and methylprednisolone plus NAC treatments have potential biochemical benefits in preventing secondary injury in experimental spinal cord injury in rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209390

Source DB:  PubMed          Journal:  Ulus Travma Acil Cerrahi Derg


  3 in total

Review 1.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

2.  Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone.

Authors:  U Y Çavuş; A Yılmaz; M N Aytekin; G Taburcu; A Albayrak; S Yıldırım; I Ağır
Journal:  Eur J Trauma Emerg Surg       Date:  2013-11-21       Impact factor: 3.693

3.  Advanced Age and Neurotrauma Diminish Glutathione and Impair Antioxidant Defense after Spinal Cord Injury.

Authors:  Andrew N Stewart; Ethan P Glaser; Caitlin A Mott; William M Bailey; Patrick G Sullivan; Samir P Patel; John C Gensel
Journal:  J Neurotrauma       Date:  2022-07-13       Impact factor: 4.869

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.